{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T10:28:11Z","timestamp":1746008891624},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>The aim of the study was to identify whether lymphocyte hydrogen sulfide production is a potential biomarker to predict intravenous immunoglobulin (IVIG) resistance in children with Kawasaki disease (KD).<\/jats:p>\n            <jats:p>This preliminary, single-center, case\u2013control study conducted between June 2016 and March 2018 in Shaanxi Provincial People's Hospital, 85 children (50 with KD and 35 healthy controls) were included. Laboratory biomarkers were collected from the medical records. All patients with KD received 1\u200ag\/kg\/d IVIG for 2 days and 30\u201350\u200amg\/kg\/d oral aspirin. The aspirin dose was reduced from 3 to 5\u200amg\/kg\/d after body temperature normalized. Plasma hydrogen sulfide levels were detected using sulfide electrode. Lymphocyte hydrogen sulfide levels were detected using the human hydrogen sulfide ELISA kits at the acute stage.<\/jats:p>\n            <jats:p>Of 50 patients with KD, 31 and 19 were diagnosed with complete KD (cKD) and incomplete KD (iKD), respectively. Eleven patients with KD were resistant to IVIG treatment. The laboratory biomarker findings and levels of plasma and lymphocyte hydrogen sulfide were significantly different between the patients with KD and control group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). Moreover, lymphocyte hydrogen sulfide production was significantly greater in IVIG-resistant patients than in the IVIG-responsive patients, both in cKD and iKD (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.018 and <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001 respectively). Receiver operating characteristic curve indicated that when the lymphocyte hydrogen sulfide production was &gt;15.285\u200anmol\/min\/10<jats:sup>8<\/jats:sup> lymphocytes, the sensitivity and specificity for predicting IVIG resistance were 90.9% and 76.9%, respectively.<\/jats:p>\n            <jats:p>Lymphocyte hydrogen sulfide production could serve as a predictor of the therapeutic efficacy of IVIG in children with KD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000013069","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T04:27:05Z","timestamp":1542774425000},"page":"e13069","source":"Crossref","is-referenced-by-count":3,"title":["Lymphocyte hydrogen sulfide production predicts intravenous immunoglobulin resistance in children with Kawasaki disease"],"prefix":"10.1097","volume":"97","author":[{"given":"Jing","family":"Lin","sequence":"first","affiliation":[{"name":"School of Public Health, Xi\u2019an Jiaotong University, Xian"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huacai","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Urology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyong","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Third Affiliated Hospital of Medical College, Xi\u2019an Jiaotong University, Xi\u2019an, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Third Affiliated Hospital of Medical College, Xi\u2019an Jiaotong University, Xi\u2019an, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Ma","sequence":"additional","affiliation":[{"name":"School of Public Health, Xi\u2019an Jiaotong University, Xian"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1542\/peds.54.3.271","article-title":"A new infantile acute febrile mucocutaneus lymph node syndrome (MLNS) prevailing in Japan","volume":"54","author":"Kawasaki","year":"1974","journal-title":"Pediatrics"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","article-title":"A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome","volume":"324","author":"Newburger","year":"1991","journal-title":"N Engl J Med"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1542\/peds.105.6.e78","article-title":"Initial intravenous gammaglobulin treatment failure in Kawasaki disease","volume":"105","author":"Wallace","year":"2000","journal-title":"Pediatrics"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/ped.12631","article-title":"Plasma hydrogen sulfide predicts coronary artery lesions in children with Kawasaki disease","volume":"57","author":"Sun","year":"2015","journal-title":"Pediatr Int"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00431-011-1630-3","article-title":"Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan","volume":"171","author":"Sudo","year":"2012","journal-title":"Eur J Pediatr"},{"key":"R7-20230914","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001625","article-title":"Prediction for intravenous immunoglobulin resistance by using weighted genetic risk score identified from genome-wide association study in Kawasaki disease","volume":"10","author":"Kuo","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00431-008-0727-9","article-title":"Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease","volume":"168","author":"Okada","year":"2009","journal-title":"Eur J Pediatr"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jpeds.2016.12.018","article-title":"Efficacy of four scoring systems in predicting intravenous immunoglobulin resistance in children with Kawasaki disease in a children's hospital in Beijing, North China","volume":"184","author":"Song","year":"2017","journal-title":"J Pediatr"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12969-017-0149-1","article-title":"Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease","volume":"15","author":"Xie","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"e000190","DOI":"10.1136\/bmjpo-2017-000190","article-title":"Thrombospondin-2 predicts response to treatment with intravenous immunoglobulin in children with Kawasaki disease","volume":"2","author":"Yang","year":"2018","journal-title":"BMJ Paediatr Open"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3892\/etm.2017.4742","article-title":"Significance of hydrogen sulfide in sepsis-induced myocardial injury in rats","volume":"14","author":"Li","year":"2017","journal-title":"Exp Ther Med"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1210\/jc.2017-00437","article-title":"Pregnancy augments VEGF-stimulated in vitro angiogenesis and vasodilator (NO and hydrogen sulfide) production in human uterine artery endothelial cells","volume":"102","author":"Zhang","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.taap.2017.11.004","article-title":"H2S protects lipopolysaccharide-induced inflammation by blocking NF-B transactivation in endothelial cells","volume":"338","author":"Bourque","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.pharep.2017.03.021","article-title":"Na2S, a fast-releasing hydrogen sulfide donor, given as suppository lowers blood pressure in rats","volume":"69","author":"Tomasova","year":"2017","journal-title":"Pharmacol Rep"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3727\/096368917X695029","article-title":"Hydrogen sulfide reduces recruitment of CD11b+Gr-1+ cells in mice with myocardial infarction","volume":"26","author":"Wu","year":"2017","journal-title":"Cell Transplant"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1096\/fj.06-6270fje","article-title":"Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation","volume":"20","author":"Zanardo","year":"2006","journal-title":"FASEB J"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(84)91504-6","article-title":"High-dose intravenous gammaglobulin for Kawasaki disease","volume":"2","author":"Furusho","year":"1984","journal-title":"Lancet"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.ATV.0000065385.47152.FD","article-title":"Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease","volume":"23","author":"Gavin","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3346\/jkms.2005.20.4.607","article-title":"Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease","volume":"20","author":"Park","year":"2005","journal-title":"J Korean Med Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201811210-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T17:14:13Z","timestamp":1694711653000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201811210-00010"}},"subtitle":["A preliminary, single-center, case\u2013control study"],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":21,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013069","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}